Wundex Group

capiton acquires majority stake in Wundex Group

Wundex Group, with headquarters in Senden, Germany, is a leading home care provider for patients with chronic wounds. The company‘s qualified wound managers provide home care services that enable faster and more effective wound treatment and significantly reduce the workload of general care providers and physicians, backed by an integrated digital platform. In addition to treatment services, the company also offers a complete range of 60,000 home care products and decubitus systems. With its three business units: home care services, home care products and decubitus systems, Wundex has built a fully integrated unique home care offering. Following a period of strong growth that saw Wundex develop into a leading provider of wound care services in Germany, the founders decided to partner with an investor with strong sector expertise and specialization to accelerate the company‘s growth plans. Both founders will retain a significant shareholding and will continue to run the day-to-day operations of the company. capiton and management plan to grow the business organically as well as through acquisitions of smaller players in this fragmented market.

Transaction summary

capiton has acquired a majority stake from the founders and BE Beteiligungen Fonds. Financing of the transaction is provided by capiton’s current investment vehicle, capiton VI. Additional funds have been reserved to finance both organic and inorganic growth initiatives. Closing of the transaction remains subject to the customary approvals by the relevant anti-trust authorities. Sellers and buyers have agreed not to disclose the financial terms of the transaction. capiton was advised by WMC Healthcare (Commercial), KPMG (Financial), BMH (Legal), EY (Tax), Code&Co (IT), AvS (Management Audit), and Tauw (ESG).

Pressemitteilungen

capiton acquires a stake in Solvis, a sustainable heating pioneer, backing the members of the management team which remain significant shareholders in the company. Solvis is headquartered in Braunschweig, Germany. The company was founded in 1982 and retains its operations in a factory which has been inaugurated as the first zero-emission-facility in Germany in 2002. […]

BIOGGIO, SWITZERLAND – October 4, 2021 – The KD Pharma Group has acquired a 51% stake in Trigal Pharma, a company specialized in clinical research, development and marketing of medical cannabinoids, such as Cannabidiol (CBD) in a highly-purified form. “Trigal has successfully and profitably grown by being a first mover in the API market for […]

capiton acquires the majority stake in Kutterer Mauer AG, backing one of the founders, Mr. Mauer in continuing the growth story of the company. Mr. Mauer as well as other management members invest alongside capiton. Kutterer Mauer AG is a globally operating manufacturer of caps and closure solutions with >450 employees. The Group designs and […]

capiton has successfully closed a new top-up single-asset fund for its fast-growing portfolio company KD Pharma Group („KD Pharma“). This top-up fund will provide KD Pharma with the equity financing for a number of additional strategic investments, in particular add-on acquisitions as well as organic growth initiatives to transfer KD Pharma‘s unique technology and service […]

We are delighted to announce the successful acquisition of 4PICO Litho by Raith. Raith, the leading global manufacturer of precision technology for nanofabrication instrumentation, has expanded its product offering by adding direct write laser lithography systems – manufactured by 4PICO Litho – to its business strategy. In 2004 4PICO Litho, located near Eindhoven (NL) started […]

capiton acquires majority stake in Stürtz Group. Stürtz Group, headquartered in Neustadt (Wied), Germany, is a market-leading designer, producer, and marketer of automated solutions for the window production industry across the globe. The company generated approximately EUR 46 million in sales in 2020 and employs around 270 FTEs across five locations globally. Stürtz’ product portfolio […]

Dec Group acquires Extract Technology We are delighted to announce the successful acquisition of Extract Technology by Dec Group. Extract Technology is a leading provider of containment and aseptic systems for the pharmaceutical, biotech, nuclear and chemical markets. Extract is headquartered in Huddersfield (UK) with a second facility in New Lisbon (US), serving the fast-growing […]

capiton acquires majority stake in Axxence Group The management team of the Axxence Group acquires in a MBO along with capiton the leading natural aroma chemicals manufacturer from its founder, Joost van Neck. Axxence Group, headquartered in Emmerich, Germany, is a leading manufacturer and supplier of natural aroma chemicals (NACs) for the global flavour & […]

EVP Group acquires Group Korott We are delighted to announce the successful acquisition of Group Korott by EVP Group. Group Korott is a leading manufacturer and distributor of vitamins, minerals, natural cosmetics, as well as sport supplements for the Spanish consumer healthcare market. In addition to its store-brand partnering business, Korott has its own brand […]

Engelmann, with headquarters in Wiesloch, Germany, is the leading European manufacturer of smart heat meters for the sub-metering industry.

Die Cedes AG („Cedes“) mit Sitz in Landquart (Schweiz) ist ein führendes Sensortechnologie Unternehmen in der Aufzugs- und Türenindustrie. Unter Verwendung von Infrarot- und Bildverarbeitungstechnologie werden die Produkte für die Automatisierung von Aufzügen, Rolltreppen und Eingängen eingesetzt. Cedes wurde 1986 gegründet und erwirtschaftete 2019 rund CHF 55 Mio. Umsatz mit rund 320 Mitarbeitern.

Die MIP Gruppe („MIP“) ist ein international aufgestellter Hersteller und Distributor von generischen Arzneimitteln mit Schwerpunkt auf Antiinfektiva. Neben Antibiotika bietet MIP rezeptfreie Medikamente und Medizinprodukte an. Die Produkte werden größtenteils in den zwei eigenen Produktionsstandorten im Saarland, Deutschland, gefertigt. Mit ca. 400 Arzneimittelzulassungen und ca. 251 Mitarbeitern generiert MIP Umsätze i.H.v. über € 40 Mio. in 19 Ländern.